{"nct_id":"NCT01848834","title":"Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-012/KEYNOTE-012)","status":"COMPLETED","status_verified_date":"2021-05","start_date":"2013-05-07","start_date_type":"ACTUAL","primary_completion_date":"2016-04-26","primary_completion_date_type":"ACTUAL","completion_date":"2020-06-30","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}